Prostate specific membrane antigen positron emission tomography in primary prostate cancer diagnosis: First-line imaging is afoot
-
Published:2022-11
Issue:
Volume:548
Page:215883
-
ISSN:0304-3835
-
Container-title:Cancer Letters
-
language:en
-
Short-container-title:Cancer Letters
Author:
Jiao Jianhua,
Zhang Jingliang,
Li Zeyu,
Wen Weihong,
Cui Chaochao,
Zhang Qiang,
Wang Jing,
Qin WeijunORCID
Subject
Cancer Research,Oncology
Reference188 articles.
1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA A Cancer J. Clin.,2021
2. Prostate cancer, version 2.2019, NCCN clinical practice guidelines in oncology;Mohler;J. Natl. Compr. Cancer Netw.,2019
3. Prostate-specific membrane antigen PET-CT in patients with high-risk prostate cancer before curative-intent surgery or radiotherapy (proPSMA): a prospective, randomised, multicentre study;Hofman;Lancet,2020
4. The additive diagnostic value of prostate-specific membrane antigen positron emission tomography computed tomography to multiparametric magnetic resonance imaging triage in the diagnosis of prostate cancer (primary): a prospective multicentre study;Emmett;Eur. Urol.,2021
5. Mapping, genomic organization and promoter analysis of the human prostate-specific membrane antigen gene;O'Keefe;Biochim. Biophys. Acta,1998
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献